Metabolic programs define dysfunctional immune responses in severe COVID-19 patients.

Area of Science:

• Immunology
• Cellular Metabolism
• Virology

Background:

• The mechanisms underlying varying COVID-19 severity remain unclear.
• Immune cell metabolic reprogramming is crucial in viral infections.

Purpose of the Study:

• To investigate immune cell metabolic phenotypes in severe and recovered COVID-19 patients.
• To identify unique cellular markers associated with COVID-19 disease severity.

Main Methods:

• Comparative analysis of immune cell metabolism in COVID-19 patients versus other viral infections.
• Flow cytometry and gene expression profiling to characterize T-cell populations.
• In vitro experiments to assess the impact of VDAC1 inhibition and caspase activity on T-cell apoptosis.

Main Results:

• Identified a unique T-cell population with increased Voltage-Dependent Anion Channel 1 (VDAC1), linked to mitochondrial dysfunction and apoptosis.
• Higher percentages of these VDAC1+ T-cells observed in elderly patients, correlating with lymphopenia.
• Expansion of myeloid-derived suppressor cells with COVID-19-specific metabolic phenotypes observed, distinguishing severe from mild disease.
• In vitro inhibition of VDAC1 oligomerization or caspase activity reduced T-cell apoptosis.

Conclusions:

• Unique metabolic phenotypes in immune cells, particularly VDAC1+ T-cells and specific myeloid-derived suppressor cells, characterize severe COVID-19.
• These findings offer insights into immune dysfunction and potential biomarkers for predicting and managing COVID-19 severity.
• Targeting VDAC1 or caspase pathways presents a potential therapeutic strategy for metabolic dysregulation in COVID-19.